ClinicalTrials.Veeva

Menu

Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

Penn State Health logo

Penn State Health

Status

Invitation-only

Conditions

Obstructive Sleep Apnea

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to compare the relative contribution of systemic inflammation vs. Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep apnea.

Enrollment

196 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mild to moderate OSA (5≤ AHI <30)
  • BMI ≤ 45
  • Age ≥ 18
  • Men & Women

Exclusion criteria

  • AHI ≥ 30
  • BMI >45
  • Current use of steroids or anti-inflammatory medication
  • Diagnosis of insulin dependent diabetes
  • Diagnosis of autoimmune disorder
  • Shiftwork
  • Current use of CPAP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems